BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7144841)

  • 1. Underfilling versus overflow in hepatic ascites.
    Epstein FH
    N Engl J Med; 1982 Dec; 307(25):1577-8. PubMed ID: 7144841
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in renal function and the intracellular environment in cirrhotic patients].
    Tiberio López G; Tanco S; Orradre B; Berrade MF; Anderiz López M
    Rev Esp Enferm Apar Dig; 1985 Apr; 67(4):367-78. PubMed ID: 2988084
    [No Abstract]   [Full Text] [Related]  

  • 3. Deranged sodium homeostasis in cirrhosis.
    Epstein M
    Gastroenterology; 1979 Mar; 76(3):622-35. PubMed ID: 428715
    [No Abstract]   [Full Text] [Related]  

  • 4. [Renal and extra-renal mechanisms of sodium and water retention in cirrhosis with ascites].
    Peña JC
    Rev Invest Clin; 1995; 47(1):63-79. PubMed ID: 7777718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.
    Bichet DG; Van Putten VJ; Schrier RW
    N Engl J Med; 1982 Dec; 307(25):1552-7. PubMed ID: 6755251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 'overflow' theory of ascites formation: a fading concept?
    Henriksen JH
    Scand J Gastroenterol; 1983 Oct; 18(7):833-7. PubMed ID: 6374865
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenesis of ascites in cirrhosis.
    Arroyo V; Badalamenti S; Ginès P
    Minerva Med; 1987 May; 78(10):645-50. PubMed ID: 3587709
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathophysiology of sodium retention and ascites formation in cirrhosis: role of atrial natriuretic factor.
    Wong F; Blendis L
    Semin Liver Dis; 1994 Feb; 14(1):59-70. PubMed ID: 8016663
    [No Abstract]   [Full Text] [Related]  

  • 9. Ascites in liver diseases.
    Gentilini P; Laffi G
    Ann Ital Med Int; 1991; 6(1 Pt 2):148-55. PubMed ID: 1742150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites.
    Cárdenas A; Arroyo V
    Best Pract Res Clin Endocrinol Metab; 2003 Dec; 17(4):607-22. PubMed ID: 14687592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal failure in advanced liver disease.
    Baldus WP
    Prog Liver Dis; 1972; 4():251-67. PubMed ID: 4347066
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology of ascites formation in cirrhosis of the liver.
    Gerbes AL
    Hepatogastroenterology; 1991 Oct; 38(5):360-4. PubMed ID: 1765351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxes of body fluid volume regulation in health and disease. A unifying hypothesis.
    Schrier RW; Niederberger M
    West J Med; 1994 Oct; 161(4):393-408. PubMed ID: 7817551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume homoeostasis in cirrhosis of the liver. Pathogenetic and therapeutic implications.
    Koomans HA; Van Hattum J; Speelberg B
    Neth J Med; 1986; 29(7):212-20. PubMed ID: 3528875
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatorenal disorders: role of the sympathetic nervous system.
    Henriksen JH; Ring-Larsen H
    Semin Liver Dis; 1994 Feb; 14(1):35-43. PubMed ID: 8016660
    [No Abstract]   [Full Text] [Related]  

  • 16. Hyperinsulinemia in preascitic cirrhosis: effects on systemic and renal hemodynamics, sodium homeostasis, forearm blood flow, and sympathetic nervous activity.
    Wong F; Logan A; Blendis L
    Hepatology; 1996 Mar; 23(3):414-22. PubMed ID: 8617419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Water and sodium metabolism in non-compensated hepatic cirrhosis: therapeutic indications according to the Arroyo classification].
    Cavatorta F; Queirolo C; Brignole M; Zangani F
    Clin Ter; 1980 Jan; 92(2):143-53. PubMed ID: 7389274
    [No Abstract]   [Full Text] [Related]  

  • 18. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 19. Naloxone increases water and electrolyte excretion after water loading in patients with cirrhosis and ascites.
    Leehey DJ; Gollapudi P; Deakin A; Reid RW
    J Lab Clin Med; 1991 Nov; 118(5):484-91. PubMed ID: 1940589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sympathetic activity in cirrhosis.
    N Engl J Med; 1983 Apr; 308(17):1029-32. PubMed ID: 6835311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.